ANI Pharmaceuticals, Inc. Insider Transactions
ANI Pharmaceuticals, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC. |
Sell | 400 @ $59.54 | $23.82 K | 83,478 | 02/13/2025 | 02/18/2025 | |
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC. |
Sell | 400 @ $53.92 | $21.57 K | 55,588 | 01/13/2025 | 01/13/2025 | |
|
CAREY STEPHEN P.
SVP & CFO |
Sell | 7,500 @ $55.79 | $418.43 K | 154,468 | 12/17/2024 | 12/18/2024 | |
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC. |
Sell | 250 @ $56.24 | $14.06 K | 55,988 | 12/13/2024 | 12/16/2024 | |
|
Davis Krista
SVP, CHIEF HR OFFICER |
Sell | 1,000 @ $60.00 | $60.00 K | 49,059 | 12/11/2024 | 12/12/2024 | |
|
Lalwani Nikhil
CEO |
Sell | 30,000 @ $57.95 | $1.74 M | 373,859 | 11/26/2024 | 11/27/2024 | |
|
Lalwani Nikhil
CEO |
Sell | 3,481 @ $58.30 | $202.94 K | 370,378 | 11/26/2024 | 11/27/2024 | |
|
Mutz Christopher
HEAD OF RARE DISEASE |
Sell | 6,500 @ $57.70 | $375.05 K | 76,777 | 11/15/2024 | 11/18/2024 | |
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC. |
Sell | 250 @ $61.36 | $15.34 K | 56,238 | 11/13/2024 | 11/14/2024 | |
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC. |
Sell | 250 @ $57.19 | $14.30 K | 56,488 | 10/14/2024 | 10/15/2024 | |
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC. |
Sell | 250 @ $56.82 | $14.21 K | 56,738 | 09/13/2024 | 09/16/2024 | |
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC. |
Sell | 250 @ $59.62 | $14.91 K | 56,988 | 08/13/2024 | 08/14/2024 | |
|
Shanmugam Muthusamy
Director, HEAD OF R&D, COO-NOVITIUM OPS |
Sell | 2,743 @ $62.00 | $170.07 K | 632,620 | 07/18/2024 | 07/19/2024 | |
|
Shanmugam Muthusamy
Director, HEAD OF R&D, COO-NOVITIUM OPS |
Sell | 14,257 @ $63.16 | $900.47 K | 635,363 | 07/17/2024 | 07/17/2024 | |
|
Shanmugam Muthusamy
Director, HEAD OF R&D, COO-NOVITIUM OPS |
Sell | 22,000 @ $64.27 | $1.41 M | 649,620 | 07/16/2024 | 07/17/2024 | |
|
Shanmugam Muthusamy
Director, HEAD OF R&D, COO-NOVITIUM OPS |
Sell | 11,000 @ $63.38 | $697.18 K | 671,620 | 07/15/2024 | 07/17/2024 | |
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC. |
Sell | 250 @ $64.91 | $16.23 K | 58,981 | 07/12/2024 | 07/15/2024 | |
|
Gassert Chad
SVP - CORP. DEV. & STRATEGY |
Sell | 20,000 @ $63.44 | $1.27 M | 193,226 | 07/01/2024 | 07/02/2024 | |
|
Shanmugam Muthusamy
Director, HEAD OF R&D, COO-NOVITIUM OPS |
Sell | 20,000 @ $58.90 | $1.18 M | 682,620 | 06/21/2024 | 06/24/2024 | |
|
Shanmugam Muthusamy
Director, HEAD OF R&D, COO-NOVITIUM OPS |
Sell | 11,447 @ $59.86 | $685.22 K | 702,620 | 06/20/2024 | 06/20/2024 |
ANI Pharmaceuticals, Inc. FAQ's
The list of insiders at ANI Pharmaceuticals, Inc. includes Cook Meredith, Davis Krista, Gutwerg Ori, Shanmugam Muthusamy, Mutz Christopher, Rowland Thomas Andrew, Lalwani Nikhil, CAREY STEPHEN P., HAUGHEY THOMAS, Walsh Patrick D, Gassert Chad, Thoma Jeanne, Leonard Matthew J, Pera Antonio R, TANNENBAUM RENEE P.
Insiders have sold a total of 457.04 K ANI Pharmaceuticals, Inc. shares in the last 12 months for a total of 39.84 M sold.
The following insiders have sold ANI Pharmaceuticals, Inc. shares in the last 12 months: Cook Meredith ($319.54 K), Davis Krista ($501.00 K), Gutwerg Ori ($884.16 K), Shanmugam Muthusamy ($17.91 M), Mutz Christopher ($241.80 K), Rowland Thomas Andrew ($426.41 K), Lalwani Nikhil ($4.89 M), CAREY STEPHEN P. ($4.30 M), HAUGHEY THOMAS ($1.66 M), Walsh Patrick D ($1.55 M), Gassert Chad ($3.05 M), Thoma Jeanne ($1.92 M), Leonard Matthew J ($840.72 K), Pera Antonio R ($1.18 M), TANNENBAUM RENEE P ($146.07 K),